- 18 December 2015 Genethon and CRISPR Therapeutics announce Research Collaboration
- 5 October 2015 The treatment of rare diseases requires extreme refinement (La Recherche)
- 28 July 2015 Genethon:a gene therapy drug being tested in the US
Created in 1990 by AFM-TELETHON, Genethon is fully dedicated to the design, development and production of gene therapy treatments for rare diseases. Its objective is to provide these innovative treatments to patients affected with rare disorders.
Genethon is developing therapies for rare neuromuscular diseases, immune system or blood disorders, eye disorders, liver and nervous system diseases.